ArticleClinical pharmacology and therapeutics2026
Population Pharmacokinetics and Exposure-Response Analyses to Support Cofetuzumab Pelidotin (ABBV-647) Dose Optimization in Non-Small Cell Lung Cancer Patients.
Carla Biesdorf et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.